|Bid||11.80 x 1300|
|Ask||35.37 x 1000|
|Day's Range||24.05 - 24.06|
|52 Week Range||20.83 - 26.01|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||-10.96%|
|Beta (5Y Monthly)||0.00|
|Expense Ratio (net)||0.18%|
Yahoo Finance's Anjalee Khemlani details Moderna's interim data on its latest flu vaccine reported to provide protection from multiple flu strains.
University of Saskatchewan Vaccine and Infectious Disease Organization Virologist Angela Rasmussen joins Yahoo Finance Live to discuss the latest on the coronavirus and the Omicron variant.
First emergency use authorization in the United States for a COVID-19 vaccine booster in individuals 16 years and older NEW YORK and MAINZ, Germany, December 9, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 vaccine to include individuals 16 years of age and older. The booster dose is to be administered at least six m